Potential mechanisms for lung fibrosis associated with COVID-19 infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential mechanisms for lung fibrosis associated with COVID-19 infection
Authors
Keywords
-
Journal
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-08-25
DOI
10.1093/qjmed/hcac206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological sequelae of long-haul COVID
- (2022) Saurabh Mehandru et al. NATURE IMMUNOLOGY
- Lung Transplantation for Covid-19–Related Respiratory Failure in the United States
- (2022) Amy Roach et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19
- (2022) Vinicius M. Fava et al. Science Advances
- Six-Month Follow-up Chest CT findings after Severe COVID-19 Pneumonia
- (2021) Xiaoyu Han et al. RADIOLOGY
- Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
- (2021) João Fadista et al. EBioMedicine
- A molecular single-cell lung atlas of lethal COVID-19
- (2021) Johannes C. Melms et al. NATURE
- COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
- (2021) Toni M. Delorey et al. NATURE
- The spatial landscape of lung pathology during COVID-19 progression
- (2021) André F. Rendeiro et al. NATURE
- Virus-induced senescence is driver and therapeutic target in COVID-19
- (2021) Soyoung Lee et al. NATURE
- Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation
- (2021) Abdallah Flaifel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
- (2021) Daniel Wendisch et al. CELL
- A single-cell transcriptomic landscape of the lungs of patients with COVID-19
- (2021) Si Wang et al. NATURE CELL BIOLOGY
- Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
- (2021) Felice D’Agnillo et al. Science Translational Medicine
- Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β
- (2021) Chiara Colarusso et al. Biomedicines
- Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients
- (2020) Jiangping He et al. Protein & Cell
- Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients
- (2020) Zhong-Jie Hu et al. Frontiers in Immunology
- Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation
- (2020) Scott W Aesif et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Lung transplantation for patients with severe COVID-19
- (2020) Ankit Bharat et al. Science Translational Medicine
- Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients
- (2020) Changfu Yao et al. Cell Reports
- Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis
- (2013) Xiaoyan Tang et al. AMERICAN JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started